News & Updates

Show Multimedia Only

AKI post-AMI tied to more serious kidney outcomes

19 Nov 2021 by

Patients who develop acute kidney injury (AKI) following an acute myocardial infarction (AMI) have an elevated risk of more serious kidney outcomes including persistent reductions in estimated glomerular filtration rate (eGFR), end-stage renal disease (ESRD), or renal death, according to results of the PARADISE-MI trial.

AKI post-AMI tied to more serious kidney outcomes

19 Nov 2021

MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA

19 Nov 2021

Fusion biopsy with magnetic resonance imaging and ultrasonography (MRI/US) is an efficient method of detecting clinically significant prostate cancer (csPCa) in biopsy-naïve men with prostate specific antigen (PSA) levels 4–10 ng/mL, a new study has found.

MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA

19 Nov 2021

Protease-based liquid biopsy a promising approach for diagnosing fatty liver disease

19 Nov 2021 by

A liquid biopsy platform that utilizes protease biosensors can detect nonalcoholic steatohepatitis with pinpoint accuracy in both mice and humans.

Protease-based liquid biopsy a promising approach for diagnosing fatty liver disease

19 Nov 2021

Re-evaluate hs-cTnT cutoffs for MI type 5: study

19 Nov 2021

Postoperative levels of high-sensitivity cardiac troponin T (hs-cTnT) often surpass defined cut-off values for myocardial infarction type 5 (MI-5; also known as peri-procedural MI), indicating the need to reassess current definitions, a recent study has found.

Re-evaluate hs-cTnT cutoffs for MI type 5: study

19 Nov 2021

Moderate-intensity exercise improves muscle performance in statin users

19 Nov 2021

A moderate-intensity endurance and resistance exercise training programme results in better muscle performance, capillarization, and mitochondrial content in both asymptomatic and symptomatic statin users without exacerbating muscle complaints, a study has shown. In addition, exercise training may even improve quality of life in symptomatic statin users.

Moderate-intensity exercise improves muscle performance in statin users

19 Nov 2021

Virtual on par with face-to-face healthcare QI workshop during COVID-19 pandemic

19 Nov 2021 by

The virtual interactive Blended Quality Improvement (QI) Workshop is as effective as the face-to-face programme based on learner’s views and gains in healthcare QI knowledge after the workshop, according to a Singapore study.

Virtual on par with face-to-face healthcare QI workshop during COVID-19 pandemic

19 Nov 2021

Energy-restricted Mediterranean diet plus physical activity improves HDL function

19 Nov 2021

An energy-restricted Mediterranean diet combined with physical activity (PA) results in better high-density lipoprotein (HDL) triglyceride metabolism compared with a nonrestrictive diet without PA in older adults with metabolic syndrome (MetS), reports a study.

Energy-restricted Mediterranean diet plus physical activity improves HDL function

19 Nov 2021

Lanadelumab demonstrates sustained efficacy for HAE

19 Nov 2021 by

The monoclonal antibody lanadelumab demonstrated long-term efficacy for patients with hereditary angioedema (HAE) who had received prophylactic lanadelumab for ≥12 months, according to findings from the post hoc analysis of the phase III HELP OLE* study presented at ACAAI 2021.

Lanadelumab demonstrates sustained efficacy for HAE

19 Nov 2021

COVID-19 vaccines weaker in liver transplant recipients, CLD patients

19 Nov 2021 by

Vaccines against the coronavirus disease 2019 (COVID-19) induce weaker and more transient immune responses in liver transplant recipients, those with cirrhosis, or those with chronic liver disease (CLD), according to a study presented at The Liver Meeting Digital Experience 2021 by the American Association for the Study of Liver Diseases (AASLD 2021).

COVID-19 vaccines weaker in liver transplant recipients, CLD patients

19 Nov 2021

No trade-off between bleeding and ischaemic risk with abbreviated DAPT

19 Nov 2021 by

Stopping dual antiplatelet therapy (DAPT) after 1 month appeared safe in high-bleeding risk (HBR) patients with acute myocardial infarction (MI) who were implanted with a newer coronary stent, a prespecified subanalysis of the MASTER DAPT* trial has shown.

No trade-off between bleeding and ischaemic risk with abbreviated DAPT

19 Nov 2021

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

AKI post-AMI tied to more serious kidney outcomes

AKI post-AMI tied to more serious kidney outcomes

MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA

MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA

Protease-based liquid biopsy a promising approach for diagnosing fatty liver disease

Protease-based liquid biopsy a promising approach for diagnosing fatty liver disease

Re-evaluate hs-cTnT cutoffs for MI type 5: study

Re-evaluate hs-cTnT cutoffs for MI type 5: study

Moderate-intensity exercise improves muscle performance in statin users

Moderate-intensity exercise improves muscle performance in statin users

Virtual on par with face-to-face healthcare QI workshop during COVID-19 pandemic

Virtual on par with face-to-face healthcare QI workshop during COVID-19 pandemic

Energy-restricted Mediterranean diet plus physical activity improves HDL function

Energy-restricted Mediterranean diet plus physical activity improves HDL function

Lanadelumab demonstrates sustained efficacy for HAE

Lanadelumab demonstrates sustained efficacy for HAE

COVID-19 vaccines weaker in liver transplant recipients, CLD patients

COVID-19 vaccines weaker in liver transplant recipients, CLD patients

No trade-off between bleeding and ischaemic risk with abbreviated DAPT

No trade-off between bleeding and ischaemic risk with abbreviated DAPT